α‐Synuclein contributes to GSK‐3β‐catalyzed Tau phosphorylation in Parkinson's disease models

10.1016/j.molmed.2009.01.003

10.1021/bi050402p

10.1111/j.1750-3639.2000.tb00269.x

10.1385/JMN:17:2:225

10.1016/S0006-8993(00)03082-1

10.1046/j.1365-2990.2003.00470.x

10.1001/archneur.61.12.1915

10.1007/s00401-003-0670-9

10.1177/153331750502000506

10.1002/1531-8249(199903)45:3<353::AID-ANA11>3.0.CO;2-4

10.1016/S0006-8993(99)01848-X

Ishizawa T., 2003, Colocalization of tau and alpha-synuclein epitopes in Lewy bodies, J. Neuropathol. Exp. Neurol., 4, 389, 10.1093/jnen/62.4.389

10.1016/j.expneurol.2004.07.016

10.1016/j.neuroscience.2008.01.030

10.1016/j.expneurol.2004.12.002

Frasier M., 2004, Following the leader: fibrillization of alpha-synuclein and tau, Exp. Neurol., 187, 235, 10.1016/j.expneurol.2004.02.008

10.1111/j.1750-3639.1999.tb00548.x

10.1096/fj.06-6092com

Lovestone S., 1994, Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells, Curr. Biol., 4, 1077, 10.1016/S0960-9822(00)00246-3

10.1074/jbc.272.40.25326

10.1016/S0014-5793(97)00688-1

10.1046/j.1471-4159.2002.01269.x

10.1016/j.brainres.2004.01.071

10.1074/jbc.273.32.19929

10.1074/jbc.275.11.7583

10.1096/fj.04-1551fje

10.1002/cmdc.200500039

10.1016/j.neuropharm.2007.03.017

10.1016/S0006-8993(02)03396-6

10.1016/j.neuro.2004.05.002

10.1126/science.287.5456.1265

10.1016/S0014-4886(03)00353-4

10.1096/fj.03-0152fje

10.1007/BF03033329

10.1016/S0091-679X(08)61583-6

10.1016/j.brainres.2007.10.018

10.1074/jbc.M105725200

10.1021/bi0341152

10.1523/JNEUROSCI.20-07-02567.2000

10.1042/bj3590001

10.1023/B:TRAG.0000040039.44899.6f

Luna-Muñoz J., Regional conformational change involving phosphorylation of tau protein at the Thr231, precedes the structural change detected by Alz-50 antibody in Alzheimer's disease, J. Alzheimers Dis., 8, 29, 10.3233/JAD-2005-8104

10.1074/jbc.C400412200

10.1038/35096075

10.1073/pnas.190297597

10.1016/S0140-6736(04)17104-3

10.1126/science.1090278

10.1523/JNEUROSCI.22-07-02780.2002

10.1016/j.bbadis.2008.10.009

10.1111/j.1471-4159.2005.03543.x

Kawakami F., 2007, Biochemical characterization of phospholipids, sulfatide and heparin as potent stimulators for autophosphorylation of GSK-3β and the GSK-3β-mediated phosphorylation of myelin basic protein in vitro, J. Biochem., 143, 359, 10.1093/jb/mvm228

Lochhead P. A., A chaperone-dependent GSK3beta transitional intermediate mediates activation-loop autophosphorylation, Mol Cell., 24, 627, 10.1016/j.molcel.2006.10.009

10.1074/jbc.M211491200

Ostrerova N., α-Syn uclein shares physical and functional homology with 14-3-3 proteins, J. Neurosci., 19, 5782, 10.1523/JNEUROSCI.19-14-05782.1999

10.1111/j.1460-9568.2007.05757.x

Vadivelan S., 2008, Fragment and knowledge-based design of selective GSK-3β inhibitors using virtual screening models, Eur. J. Med. Chem.

10.3233/JAD-2008-15204

10.2353/ajpath.2007.061178

10.1002/ana.20691